India to Peru: Busulfan Export Trade Route

The India to Peru Busulfan corridor is one of India's established pharmaceutical export routes, with 4 shipments documented worth a combined $756.7K USD. The route is dominated by INTAS PHARMACEUTICALS LIMITED , which alone accounts for roughly 95% of all export value, reflecting the consolidated nature of India's busulfan manufacturing sector.

Across 3 active suppliers, the average shipment value stands at $189.2K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 82% of all shipments, consistent with busulfan's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 22.8%, placing it at rank #8 among India's top busulfan export destinations globally.

On the import side, key buyers of Indian busulfan in Peru include ACCORD HEALTHCARE S.A.C. , ACCORD HEALTHCARE S A C, EMCURE PHARMA PERU SOCIEDAD ANONIMA. ACCORD HEALTHCARE S.A.C. is the single largest importer with 2 shipments valued at $716.8K USD.

India's busulfan exports to Peru are driven primarily by a handful of large-scale manufacturers. INTAS PHARMACEUTICALS LIMITED with 2 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 3 active exporters signals a competitive but concentrated market — buyers in Peru benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — INTAS PHARMACEUTICALS LIMITED , INTAS PHARMACEUTICALS LTD, EMCURE PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $189.2K USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as ph.dru. & med.: bufancord busulfan concentrate for solution for infusion 6mg/mleach ml cont. busulfan ph.eur 6mg [1x1 and pharmac products(finished product)(generic name) emsulfan 60 mg inj 1 vial busulfan injection 60mg/10ml ), suggesting that buyers in Peru tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, ACCORD HEALTHCARE S.A.C. is the largest importer with 2 shipments worth $716.8K USD — representing 95% of all busulfan imports from India on this route.